Original Research

When to start antiretroviral therapy in infants and children

Mark F Cotton, Helena Rabie, Ute Feucht, Avy Violari
Southern African Journal of HIV Medicine | Vol 10, No 4 | a261 | DOI: https://doi.org/10.4102/sajhivmed.v10i4.261 | © 2009 Mark F Cotton, Helena Rabie, Ute Feucht, Avy Violari | This work is licensed under CC Attribution 4.0
Submitted: 15 December 2009 | Published: 14 December 2009

About the author(s)

Mark F Cotton, KID-CRU, South Africa
Helena Rabie, Tygerberg Children's Hospital, South Africa
Ute Feucht, Kalafong Hospital, South Africa
Avy Violari, Perinatal HIV Research Unit, South Africa

Full Text:

PDF (349KB)

Share this article

Bookmark and Share


This articles provides a background for antiretroviral therapy in infants and children, incorporating both old and new data. There is increasing data favouring early therapy for all age groups. Below a year of age, all HIV-infected infants should commence therapy and thereafter at higher CD4 thresholds than previous recommendations


No related keywords in the metadata.


Total abstract views: 2023
Total article views: 1480


Crossref Citations

1. Working Memory Profiles in HIV-Exposed, Uninfected and HIV-Infected Children: A Comparison with Neurotypical Controls
Robyn Milligan, Kate Cockcroft
Frontiers in Human Neuroscience  vol: 11  year: 2017  
doi: 10.3389/fnhum.2017.00348